Detalles de la búsqueda
1.
A Phase I Study of an IDO-1 Inhibitor (LY3381916) as Monotherapy and in Combination With an Anti-PD-L1 Antibody (LY3300054) in Patients With Advanced Cancer.
J Immunother
; 44(7): 264-275, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33928928
2.
Safety and Antitumor Activity of α-PD-L1 Antibody as Monotherapy or in Combination with α-TIM-3 Antibody in Patients with Microsatellite Instability-High/Mismatch Repair-Deficient Tumors.
Clin Cancer Res
; 27(23): 6393-6404, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34465599
Resultados
1 -
2
de 2
1
Próxima >
>>